CN Patent

CN104803977A — 一种含四氮唑结构的ptp1b衍生物、其制备方法及用途

Assigned to Foshan Saiweisi Pharmaceutical Technology Co Ltd · Expires 2015-07-29 · 11y expired

What this patent protects

本发明涉及与II型糖尿病相关的药物领域。具体而言，本发明涉及一种含四氮唑结构的PTP1B抑制剂衍生物、其制备方法，以及在制备2型糖尿病药物中的应用。

USPTO Abstract

本发明涉及与II型糖尿病相关的药物领域。具体而言，本发明涉及一种含四氮唑结构的PTP1B抑制剂衍生物、其制备方法，以及在制备2型糖尿病药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN104803977A
Jurisdiction
CN
Classification
—
Expires
2015-07-29
Drug substance claim
No
Drug product claim
No
Assignee
Foshan Saiweisi Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.